iSpecimen Inc (ISPC)
4.34
-0.24
(-5.24%)
USD |
NASDAQ |
Nov 22, 16:00
4.34
0.00 (0.00%)
After-Hours: 16:30
iSpecimen Profit Margin (Quarterly): -54.09% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -54.09% |
| June 30, 2024 | -73.65% |
| March 31, 2024 | -126.7% |
| December 31, 2023 | -119.3% |
| September 30, 2023 | -76.00% |
| June 30, 2023 | -214.4% |
| March 31, 2023 | -82.43% |
| December 31, 2022 | -72.92% |
| September 30, 2022 | -119.8% |
| June 30, 2022 | -111.5% |
| March 31, 2022 | -94.64% |
| Date | Value |
|---|---|
| December 31, 2021 | -80.44% |
| September 30, 2021 | -57.13% |
| June 30, 2021 | -48.04% |
| March 31, 2021 | -133.7% |
| December 31, 2020 | -58.64% |
| September 30, 2020 | -55.40% |
| June 30, 2020 | -11.57% |
| March 31, 2020 | -95.70% |
| December 31, 2019 | -104.5% |
| September 30, 2019 | -304.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-214.4%
Minimum
Jun 2023
-11.57%
Maximum
Jun 2020
-89.53%
Average
-81.43%
Median
Profit Margin (Quarterly) Benchmarks
| RadNet Inc | 0.70% |
| 23andMe Holding Co | -134.1% |
| Delcath Systems Inc | 16.64% |
| CytoSorbents Corp | -27.10% |
| Progyny Inc | 3.64% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -118.9% |
| Return on Assets | -70.24% |
| Return on Invested Capital | -116.3% |
| Gross Profit Margin (Quarterly) | 41.62% |
| Operating Margin (Quarterly) | -64.07% |
| Return on Net Operating Assets | -97.40% |